Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rehabilitation Hospital of the Pacific | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The investigators are doing this study to determine if there are body composition changes after a 12-week exercise program in breast cancer patients and determine what factors contribute to sustained physical activity after the 12-week exercise program intervention.
The study is enrolling breast cancer patients up to 2 years after their diagnosis in a 12-week exercise program. The participants will either participate in: Group 1-participating in an exercise program with biometric evaluations or Group 2-biometric evaluations but not participating in the exercise program. At the end of the 12-week exercise program, participants in Group 1 will be randomized to either: a) continuing with exercise group classes or b) continuing with exercise individual classes. Both Group 1a and 1b participants will be followed for the remainder of the year and be evaluated for continued physical activity. All Group study participants' biometrics will be assessed at baseline and at the end of 12-weeks, with continued annual medical review follow-up for a total of 5 years.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 - Agree to Exercise Program | Active Comparator | 12-week exercise program |
|
| Group 2 - Declines Exercise Program | No Intervention | Same biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise | Other | First Intervention 12-week exercise program, 3 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Private or semi-private (1:1 or 2:1 ratio participant to instructor) sessions, led by Kinesiology students Second Intervention- 12-week exercise program, 2 days/week, 90min exercise sessions at the Rehabilitation Hospital of the Pacific. Group Fitness Classes |
| Measure | Description | Time Frame |
|---|---|---|
| Fat mass | Measure fat mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data | 1 day |
| Isometric peak torque | Measure the peak torque value generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device | 1 day |
| Lean mass | Measure lean mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data | 1 day |
| Bone mass | Measure bone mass (arms, legs, trunk and total) in kg using Dual energy X-ray absorptiometry (DXA) data | 1 day |
| Waist to Hip ratio (WHR) from manual tape measurement | Manual physical anthropometry of waist and hip circumferences | 1 day |
| Automatic 3D optical (3DO) scan measurement: girth measurement | Automated 3DO measurements generate the following: girth in cm measurements across the whole body | 1 day |
| Muscle Function | Measure the peak torque value generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device | 1 day |
| Percent fat |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence Free Survival | obtained from last physician note | 5 years |
| BIBCQ-Body Image After Breast Cancer questionnaire | 45 items | 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jami Fukui, MD | University of Hawaii Cancer Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Hawaii Cancer Center | Honolulu | Hawaii | 96813 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Participants choose the initial intervention (12-week exercise program (Group1) vs monitoring (Group2)).
Not provided
Not provided
Not provided
Not provided
|
Percent fat (arms, legs, trunk and total) using Dual energy X-ray absorptiometry (DXA) data |
| 1 day |
| Automatic 3D optical (3DO) scan measurement: length measurement | Automated 3DO measurements generate the following: length in cm measurements across the whole body | 1 day |
| Automatic 3D optical (3DO) scan measurement: volume measurement | Automated 3DO measurements generate the following: volume in cm measurements across the whole body | 1 day |
| Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data | Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data | 1 day |
| BFI-Brief Fatigue Innovatory questionnaire | 9 items | 5 years |
| PHQ-9- Patient Health (Depression) questionnaire | 9 items | 5 years |
| FACT-G-Functional Assessment of Cancer Therapy-General (Comorbidities)questionnaire | 27 items | 5 years |
| Diet History Questionnaire II | Self-reported energy intake, measured as kcal/day | 5 years |
| Biomarkers | Adipokines: leptin, HMW-high molecular weight adiponectin, PAI1-plasminogen activator inhibitor Cytokines & Inflammation: TNF-tumor necrosis factor α, IL-interleukin 1β, IL2, IL4, IL5, IL6, IL8, IL10, interferon, CRP-C reactive protein, uric acid, cortisol Insulin Resistance & IGFs: glucose, insulin, Hb-hemoglobin A1C, IGF-insulin growth factor 1, IGFBP-insulin like growth factor binding protein 1-3 Sex Steroid Hormones: total estradiol & estrone, total testosterone, SHBG-sex hormone-binding globulin (for free estradiol and free testosterone will be derived) Lipid Profile & Lipid-soluble Micronutrients: TG-triglycerides , total cholesterol, HDLC-high density lipoprotein cholesterol , free fatty acids, lycopene, 25OH-vitamin D3, alpha-tocopherol Liver Enzymes: ALT-alanine aminotransferase Neuropeptides & Gut Hormones: ghrelin MOTS-mitochondrial derived peptide-c | 5 years |
| D017437 |
| Skin and Connective Tissue Diseases |